Header cover image

Swedish (OMX) Healthcare Sector Analysis

UpdatedJul 26, 2024
DataAggregated Company Financials
Companies185
  • 7D0.8%
  • 3M12.1%
  • 1Y24.7%
  • YTD9.1%

The Healthcare is pretty flat in the last 7 days, but Swedish Orphan Biovitrum has stood out, gaining 5.2%. As for the the longer term, the industry is up 25% over the past 12 months. Earnings are forecast to grow by 37% annually.

Sector Valuation and Performance

Has the Swedish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jul 2024SEK 598.9bSEK 199.0b-SEK 2,856,203,905.9141.8x-209.7x3x
Sun, 23 Jun 2024SEK 557.3bSEK 195.5b-SEK 3,182,934,253.1735.3x-175.1x2.9x
Tue, 21 May 2024SEK 552.5bSEK 196.2b-SEK 2,920,427,970.2037.4x-189.2x2.8x
Thu, 18 Apr 2024SEK 516.4bSEK 193.1b-SEK 3,172,396,485.6844.5x-162.8x2.7x
Sat, 16 Mar 2024SEK 521.6bSEK 192.3b-SEK 3,668,382,588.5343.5x-142.2x2.7x
Mon, 12 Feb 2024SEK 509.6bSEK 191.4b-SEK 4,204,413,743.1548.9x-121.2x2.7x
Wed, 10 Jan 2024SEK 549.1bSEK 191.3b-SEK 965,498,035.0048.3x-568.8x2.9x
Fri, 08 Dec 2023SEK 507.1bSEK 190.3b-SEK 1,098,047,905.0050.3x-461.8x2.7x
Sun, 05 Nov 2023SEK 458.1bSEK 190.0b-SEK 1,067,305,617.0040.3x-429.2x2.4x
Tue, 03 Oct 2023SEK 450.7bSEK 185.0b-SEK 2,028,250,505.0036.3x-222.2x2.4x
Thu, 31 Aug 2023SEK 461.7bSEK 185.7b-SEK 1,770,203,896.0037.5x-260.8x2.5x
Sat, 29 Jul 2023SEK 478.8bSEK 183.7b-SEK 1,025,280,705.0040.3x-467x2.6x
Mon, 26 Jun 2023SEK 483.3bSEK 179.1b-SEK 798,027,738.0043.6x-605.6x2.7x
Wed, 24 May 2023SEK 520.4bSEK 177.5b-SEK 841,964,752.0043.5x-618.1x2.9x
Fri, 21 Apr 2023SEK 507.3bSEK 173.0b-SEK 1,518,275,789.0035x-334.1x2.9x
Sun, 19 Mar 2023SEK 482.8bSEK 172.3b-SEK 1,416,844,503.0035.9x-340.7x2.8x
Tue, 14 Feb 2023SEK 512.1bSEK 169.4bSEK 445.8m35.8x1148.8x3x
Thu, 12 Jan 2023SEK 493.0bSEK 165.9bSEK 698.5m32.7x705.9x3x
Sat, 10 Dec 2022SEK 491.1bSEK 165.1bSEK 800.5m32.1x613.5x3x
Mon, 07 Nov 2022SEK 468.8bSEK 163.2b-SEK 301,243,077.0029.5x-1556.3x2.9x
Wed, 05 Oct 2022SEK 456.7bSEK 159.5b-SEK 218,100,795.0028.2x-2094.2x2.9x
Fri, 02 Sep 2022SEK 474.1bSEK 159.2b-SEK 101,834,511.0030.6x-4655.9x3x
Sun, 31 Jul 2022SEK 535.9bSEK 156.7b-SEK 316,558,734.0032.3x-1692.8x3.4x
Tue, 28 Jun 2022SEK 514.1bSEK 153.9bSEK 350.1m29.9x1468.6x3.3x
Thu, 26 May 2022SEK 535.7bSEK 154.2bSEK 582.3m37.3x920x3.5x
Sat, 23 Apr 2022SEK 598.4bSEK 147.7bSEK 1.1b43.6x535.8x4.1x
Mon, 21 Mar 2022SEK 627.0bSEK 147.6bSEK 1.3b44.4x475.4x4.2x
Wed, 16 Feb 2022SEK 628.4bSEK 146.1bSEK 2.7b44.7x234.5x4.3x
Fri, 14 Jan 2022SEK 682.0bSEK 143.8bSEK 3.5b48.6x196.2x4.7x
Sun, 12 Dec 2021SEK 731.4bSEK 143.8bSEK 3.5b51.6x208.8x5.1x
Tue, 09 Nov 2021SEK 770.8bSEK 141.9bSEK 3.8b54.8x201.8x5.4x
Thu, 07 Oct 2021SEK 716.6bSEK 140.4bSEK 4.1b52.8x175.3x5.1x
Sat, 04 Sep 2021SEK 797.4bSEK 140.4bSEK 4.4b56.9x179.5x5.7x
Mon, 02 Aug 2021SEK 757.2bSEK 140.4bSEK 4.4b57.1x170.4x5.4x
Price to Earnings Ratio

170.4x


Total Market Cap: SEK 757.2bTotal Earnings: SEK 4.4bTotal Revenue: SEK 140.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Sector Price to Earnings3Y Average -667x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare sector?

SE Market-1.57%
Healthcare0.77%
Biotech3.87%
Pharma1.56%
Healthtech-0.13%
Medical Equipment-0.91%
Life Sciences-1.57%
Healthcare Services-4.06%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 379x.
    • Analysts are expecting annual earnings growth of 21.9%, which is lower than the prior year's growth of 185.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 66% over the next 5 years.
  • This is better than its past earnings decline of 36% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 22% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOBI Swedish Orphan BiovitrumSEK 299.006.8%
+SEK 6.5b		45.1%PE47.7x
CAMX CamurusSEK 669.005.2%
+SEK 1.9b		125.4%PE175.7x
GETI B GetingeSEK 209.202.9%
+SEK 1.6b		6.2%PE22.1x
IMP A SDB ImplanticaSEK 38.5010.2%
+SEK 1.0b		103.1%PS548.1x
VITR VitrolifeSEK 226.402.4%
+SEK 704.1m		41.6%PS8.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MCOV B

SEK 189.00

Medicover

7D

-5.1%

1Y

18.1%

SECARE

SEK 46.50

Swedencare

7D

-7.3%

1Y

4.4%

ALIF B

SEK 155.60

AddLife

7D

1.9%

1Y

77.8%

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26
AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

MCAP

SEK 546.00

MedCap

7D

-7.9%

1Y

74.4%

IMP A SDB

SEK 38.50

Implantica

7D

10.2%

1Y

103.1%

SEDANA

SEK 22.60

Sedana Medical

7D

-13.1%

1Y

-6.5%

VITR

SEK 226.40

Vitrolife

7D

2.4%

1Y

41.6%

DMYD B

SEK 18.02

Diamyd Medical

7D

35.3%

1Y

86.5%

BIOT

SEK 189.30

Biotage

7D

2.2%

1Y

43.4%

GETI B

SEK 209.20

Getinge

7D

2.9%

1Y

6.2%

Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

Jul 21
Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next

CAMX

SEK 669.00

Camurus

7D

5.2%

1Y

125.4%

SOBI

SEK 299.00

Swedish Orphan Biovitrum

7D

6.8%

1Y

45.1%

Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 19
Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

XVIVO

SEK 518.00

Xvivo Perfusion

7D

-3.9%

1Y

67.6%

SECT B

SEK 235.60

Sectra

7D

-0.8%

1Y

39.4%

Sectra's (STO:SECT B) Solid Earnings May Rest On Weak Foundations

Jul 11
Sectra's (STO:SECT B) Solid Earnings May Rest On Weak Foundations

BICO

SEK 42.40

BICO Group

7D

-5.9%

1Y

0.5%

BIOA B

SEK 221.60

BioArctic

7D

-1.8%

1Y

-24.7%